3,3-Dimethyl-1-butanol

Overview

3,3-Dimethyl-1-butanol (DMB) is an orally active inhibitor of trimethylamine ( TMA ) and trimethylamine N-oxide ( TMAO ). 3,3-Dimethyl-1-butanol inhibits the signaling pathway of p65 NF-κB and TGF-β1/Smad3 . 3,3-Dimethyl-1-butanol has potential applications in cardiovascular disease (CVD).

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Heart Disease | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Arthritis | Products > Disease Areas > Atherosclerosis | Products > Disease Areas > Hypertension | Products > Disease Areas > Heart Failure | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > NF-κB | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Endogenous Metabolite | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > NF-κB

Product Information

• Catalog No.: HY-W012977
• CAS No.: 624-95-3
• Molecular Formula: C6H14O
• Molecular Weight: 102.17
• Purity: 99.19%
• Storage: Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (24.47 mM); Clear solution
• Availability: In-stock

Source

Original product source